Joint Formulary & PAD

Dalteparin sodium - Pre-operative / bridging therapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Dalteparin sodium
Indication :
Pre-operative / bridging therapy
Group Name :
Keywords :
Low Molecular Weight Heparins, LMWH
Brand Names Include :
Fragmin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

28 Apr 10 - Not Set
The committee were informed that pre-operative LMWH is included within the PbR tariff and should therefore be prescribed/provided by the acute trusts. It should be noted that private patients should not receive care that is different to that of NHS patients and on that principle, the pre-operative LMWH should form part of that patients' private care

Other Indications

Below are listed other indications that Dalteparin sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pre-operative / bridging therapy.